FDA Orange Book
Generic for Benemid
Benemid contains probenecid. Orange Book status for every listed strength, the approved generic makers, and the listed patents and exclusivities.
Source: FDA Orange Book data file dated 2026-10-09. Publisher page
Yes. The generic name for Benemid is probenecid. 3 companies hold an active FDA approval (ANDA) for a generic version in the Orange Book. Therapeutic equivalence codes: AB.
Run it in Rivvi
Map Benemid and your other top fills to their generics
Every strength in RxNorm, with brands that have no generic flagged.
Build the mapFree to start. Opens Rivvi, the AI workspace for healthcare teams.
Benemid products in the Orange Book
| Form and route | Strength | Brand status | Brand TE | Active generics | Generic TE codes |
|---|---|---|---|---|---|
| tablet, oral | 500MG | Discontinued | None | 3 | AB |
NDA 007898, held by MERCK AND CO INC. Active generics are ANDA products in the Orange Book prescription list with the same ingredient, dosage form, route and strength.
Approved generic probenecid
| Company | ANDA | TE code | Approved | Strengths |
|---|---|---|---|---|
| WATSON LABORATORIES INC AN INDIRECT WHOLLY OWNED SUB OF TEVA PHARMACEUTICALS USA INC | 084442 | AB (A-rated, therapeutically equivalent) | March 29, 1983 | 500MG |
| RISING PHARMA HOLDINGS INC | 217020 | AB (A-rated, therapeutically equivalent) | November 20, 2023 | 500MG |
| LANNETT CO INC | 080966 | AB (A-rated, therapeutically equivalent) | Approved Prior to Jan 1, 1982 | 500MG |
Questions
Is there a generic for Benemid?
Yes. The generic name for Benemid is probenecid. 3 companies hold an active FDA approval (ANDA) for a generic version in the Orange Book. Therapeutic equivalence codes: AB.
What is the generic name for Benemid?
The active ingredient in Benemid is probenecid, per the FDA Orange Book.
What does a therapeutic equivalence code mean?
In the Orange Book, codes that start with A (such as AB) mean FDA considers the product therapeutically equivalent to the reference drug. Codes that start with B mean FDA does not, at this time, consider the product therapeutically equivalent.